Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial Post author:Sam Post published:February 7, 2018 Post category:BioPharma MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace You Might Also Like 5 Drugmakers That are Soaring Insanely High Right Now January 28, 2018 2 Biotechs That May Disappear by 2020 March 30, 2017 Accenture Develops Artificial Intelligence-Powered Solution To Help Improve How Visually Impaired People Live And Work July 27, 2017
Accenture Develops Artificial Intelligence-Powered Solution To Help Improve How Visually Impaired People Live And Work July 27, 2017
